Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 591

1.

Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers.

Bossen L, Gerussi A, Lygoura V, Mells GF, Carbone M, Invernizzi P.

Autoimmun Rev. 2018 Jul 11. pii: S1568-9972(18)30153-8. doi: 10.1016/j.autrev.2018.02.013. [Epub ahead of print] Review.

PMID:
30005861
2.

Hepatic Iron Overload following Liver Transplantation from a C282Y/H63D Compound Heterozygous Donor.

Veitsman E, Pras E, Pappo O, Arish A, Eshkenazi R, Feray C, Calderaro J, Azoulay D, Ari ZB.

Case Reports Hepatol. 2018 May 31;2018:4298649. doi: 10.1155/2018/4298649. eCollection 2018.

3.

Primary sclerosing cholangitis is associated with abnormalities in CFTR.

Werlin S, Scotet V, Uguen K, Audrezet MP, Cohen M, Yaakov Y, Safadi R, Ilan Y, Konikoff F, Galun E, Mizrahi M, Slae M, Sayag S, Cohen-Cymberknoh M, Wilschanski M, Ferec C.

J Cyst Fibros. 2018 May 26. pii: S1569-1993(18)30115-2. doi: 10.1016/j.jcf.2018.04.005. [Epub ahead of print]

PMID:
29807875
4.

Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis.

Salla M, Aguayo-Ortiz R, Danmaliki GI, Zare A, Said A, Moore J, Pandya V, Manaloor R, Fong S, Blankstein AR, Gibson SB, Garcia LR, Meier P, Bhullar KS, Hubbard BP, Fiteh Y, Vliagoftis H, Goping IS, Brocks D, Hwang P, Velázquez-Martínez CA, Baksh S.

J Pharmacol Exp Ther. 2018 May;365(2):354-367. doi: 10.1124/jpet.117.247163. Epub 2018 Mar 19.

PMID:
29555876
5.

Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Tedesco D, Thapa M, Chin CY, Ge Y, Gong M, Li J, Gumber S, Speck P, Elrod EJ, Burd EM, Kitchens WH, Magliocca JF, Adams AB, Weiss DS, Mohamadzadeh M, Grakoui A.

Gastroenterology. 2018 Jun;154(8):2178-2193. doi: 10.1053/j.gastro.2018.02.019. Epub 2018 Feb 15.

PMID:
29454797
6.

The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.

Torres J, Palmela C, Brito H, Bao X, Ruiqi H, Moura-Santos P, Pereira da Silva J, Oliveira A, Vieira C, Perez K, Itzkowitz SH, Colombel JF, Humbert L, Rainteau D, Cravo M, Rodrigues CM, Hu J.

United European Gastroenterol J. 2018 Feb;6(1):112-122. doi: 10.1177/2050640617708953. Epub 2017 May 5.

7.

The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.

Peng ZW, Rothweiler S, Wei G, Ikenaga N, Liu SB, Sverdlov DY, Vaid KA, Longhi MS, Kuang M, Robson SC, Popov YV.

Hepatol Commun. 2017 Sep 26;1(9):957-972. doi: 10.1002/hep4.1084. eCollection 2017 Nov.

8.

Rheumatic Manifestations in Autoimmune Liver Disease.

Selmi C, Generali E, Gershwin ME.

Rheum Dis Clin North Am. 2018 Feb;44(1):65-87. doi: 10.1016/j.rdc.2017.09.008. Review.

PMID:
29149928
9.

[NISCH syndrome, a rare cause of neonatal cholestasis: A case report].

Szepetowski S, Lacoste C, Mallet S, Roquelaure B, Badens C, Fabre A.

Arch Pediatr. 2017 Dec;24(12):1228-1234. doi: 10.1016/j.arcped.2017.09.016. Epub 2017 Nov 13. French.

PMID:
29146216
10.

Search for Genetic Modifiers of PSC: Time to Increase the Number of Needles in the Haystack.

Krawczyk M, Lammert F.

Ann Hepatol. 2017 November-December,;16(6):830-831. doi: 10.5604/01.3001.0010.5271.

11.

Updated strategies for the management, pathogenesis and molecular genetics of different forms of ichthyosis syndromes with prominent hair abnormalities.

Rasheed M, Shahzad S, Zaeem A, Afzal I, Gul A, Khalid S.

Arch Dermatol Res. 2017 Dec;309(10):773-785. doi: 10.1007/s00403-017-1780-x. Epub 2017 Sep 14. Review.

PMID:
28913623
12.

Novel CLDN1 mutation in ichthyosis-hypotrichosis-sclerosing cholangitis syndrome without signs of liver disease.

Nagtzaam IF, Peeters VPM, Vreeburg M, Wagner A, Steijlen PM, van Geel M, van Steensel MAM.

Br J Dermatol. 2018 Mar;178(3):e202-e203. doi: 10.1111/bjd.15996. Epub 2018 Jan 23. No abstract available.

PMID:
28906553
13.

Rapidly progressive atherosclerosis after domino liver transplantation from a teenage donor with homozygous familial hypercholesterolemia.

Golbus JR, Farhat L, Fontana RJ, Rubenfire M.

J Clin Lipidol. 2017 Sep - Oct;11(5):1284-1288. doi: 10.1016/j.jacl.2017.07.006. Epub 2017 Jul 22.

PMID:
28807459
14.

Primary sclerosing cholangitis - a comprehensive review.

Karlsen TH, Folseraas T, Thorburn D, Vesterhus M.

J Hepatol. 2017 Dec;67(6):1298-1323. doi: 10.1016/j.jhep.2017.07.022. Epub 2017 Aug 10. Review.

15.

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.

Pereira P, Aho V, Arola J, Boyd S, Jokelainen K, Paulin L, Auvinen P, Färkkilä M.

PLoS One. 2017 Aug 10;12(8):e0182924. doi: 10.1371/journal.pone.0182924. eCollection 2017.

16.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J, Eksteen B, Ellinghaus D, Färkkilä M, Festen EAM, Floreani A, Franceschet I, Gotthardt DN, Hirschfield GM, Hoek BV, Holm K, Hohenester S, Hov JR, Imhann F, Invernizzi P, Juran BD, Lenzen H, Lieb W, Liu JZ, Marschall HU, Marzioni M, Melum E, Milkiewicz P, Müller T, Pares A, Rupp C, Rust C, Sandford RN, Schramm C, Schreiber S, Schrumpf E, Silverberg MS, Srivastava B, Sterneck M, Teufel A, Vallier L, Verheij J, Vila AV, Vries B, Zachou K; International PSC Study Group, The UK PSC Consortium, Chapman RW, Manns MP, Pinzani M, Rushbrook SM, Lazaridis KN, Franke A, Anderson CA, Karlsen TH, Ponsioen CY, Weersma RK.

Gut. 2018 Aug;67(8):1517-1524. doi: 10.1136/gutjnl-2016-313598. Epub 2017 Aug 4.

17.

NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients.

Jüngst C, Stadlbauer V, Reichert MC, Zimmer V, Weber SN, Ofner-Ziegenfuß L, Voigtländer T, Spindelböck W, Fickert P, Kirchner GI, Lammert F, Lankisch TO, Krawczyk M.

Sci Rep. 2017 Aug 1;7(1):7026. doi: 10.1038/s41598-017-06268-y.

18.

Genetic determinants of cholangiopathies: Molecular and systems genetics.

Reichert MC, Hall RA, Krawczyk M, Lammert F.

Biochim Biophys Acta. 2018 Apr;1864(4 Pt B):1484-1490. doi: 10.1016/j.bbadis.2017.07.029. Epub 2017 Jul 27. Review.

PMID:
28757171
19.

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.

Bajer L, Kverka M, Kostovcik M, Macinga P, Dvorak J, Stehlikova Z, Brezina J, Wohl P, Spicak J, Drastich P.

World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.

20.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657

Supplemental Content

Loading ...
Support Center